Evidence map›Paper›PMID 26076186›Full record

ArticleBioconjugate chemistry2015

Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell Targeting.

Adel M ElSohly, Chawita Netirojjanakul, Ioana L Aanei, Astraea Jager, Sean C Bendall, Michelle E Farkas, Garry P Nolan, Matthew B Francis

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Tailored Viral-like Particles as Drivers of Medical Breakthroughs.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Article
  4. Strategies for Multienzyme Assemblies.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adel M ElSohly†Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
Chawita Netirojjanakul†Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
Ioana L Aanei†Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
Astraea Jager§Baxter Laboratory and Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, United States.
Sean C Bendall∥Stanford Blood Center, Stanford School of Medicine, Palo Alto, California 94304, United States.
Michelle E Farkas†Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
Garry P Nolan§Baxter Laboratory and Stem Cell Biology, Department of Microbiology and Immunology, Stanford University, Stanford, California 94305, United States.
Matthew B Francis†Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMAU54CA149145 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2010 to 2014
$12.1M
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian CancersR01CA184968 · NCI · STANFORD UNIVERSITY · PI FANTL, WENDY JANE, SIKIC, BRANIMIR I · 2014 to 2017
$2.0M
MicroRNAs as T cell sensitivity RheostatsR01AI073724 · NIAID · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2009 to 2013
$2.0M
Highly multiplexed ion-beam tissue molecular imaging with sub-micron resolutionR33CA183654 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2014 to 2016
$1.2M
Integrating mass cytometric and transcriptomic profiles of solid tumorsR33CA183692 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEISS, WILLIAM A · 2014 to 2016
$1.2M
QTOF MASS SPECTROMETER: CELL MOLECULAR BIOLOGY, PROTEIN STRUCTURES10RR022393 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI WILLIAMS, EVAN R · 2006 to 2006
$499k
Howard Hughes Medical InstituteNCI NIH HHS 1 R33 CA183654NCI NIH HHS R01 CA184968NCI NIH HHS R01CA184968NCI NIH HHS R33 CA183654NCI NIH HHS R33 CA183692NCI NIH HHS U54 CA149145NCI NIH HHS U54CA149145NCRR NIH HHS 1S10RR022393-01NCRR NIH HHS S10 RR022393NHLBI NIH HHS N01-HV-00242NIAID NIH HHS 1U19AI100627NIAID NIH HHS 5R01AI07372405NIAID NIH HHS R01 AI073724NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI100627PHS HHS HHSF223201210194C
6 · The paper itself

Abstract

The present study describes an efficient and reliable method for the preparation of MS2 viral capsids that are synthetically modified with antibodies using a rapid oxidative coupling strategy. The overall protocol delivers conjugates in high yields and recoveries, requires a minimal excess of antibody to achieve modification of more than 95% of capsids, and can be completed in a short period of time. Antibody-capsid conjugates targeting extracellular receptors on human breast cancer cell lines were prepared and characterized. Notably, conjugation to the capsid did not significantly perturb the binding of the antibodies, as indicated by binding affinities similar to those obtained for the parent antibodies. An array of conjugates was synthesized with various reporters on the interior surface of the capsids to be used in cell studies, including fluorescence-based flow cytometry, confocal microscopy, and mass cytometry. The results of these studies lay the foundation for further exploration of these constructs in the context of clinically relevant applications, including drug delivery and in vivo diagnostics.

Indexed as

Antibodies, MonoclonalBreast NeoplasmsCapsidCapsid ProteinsDrug Delivery SystemsFemaleFlow CytometryFluorescenceHumansImmunoconjugatesMicroscopy, ConfocalReceptors, Cell SurfaceVirionAntibodies, MonoclonalCapsid ProteinsImmunoconjugatesReceptors, Cell Surface

Identifiers

PMID26076186
PMCPMC4758138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.